课题基金 / 基金详情

Development of specific imuune regulatoly drugs by the cell surface molecules.

Development of specific imuune regulatoly drugs by the cell surface molecules.
利用细胞表面分子开发特异性免疫调节药物。
批准号:
10557049
负责人:
MORIMOTO Chikao
金额:
$8.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

MORIMOTO Chikao的其他基金

相似基金

相关文献

中文摘要
翻译
CD26是T细胞活化抗原,也已知与腺苷脱氨酶(ADA)结合,并具有二肽基肽酶IV (DPPIV)活性。CD26和CD3与固定的单克隆抗体交联可以传递第二种共刺激信号,并有助于T细胞活化。我们早期的研究表明,CD26的交联诱导了分子的内化,随后信号分子的酪氨酸磷酸化,并导致T细胞的增殖反应增强。尽管这些发现提示了内化在CD26功能中的重要性。CD26细胞质区只有6个氨基酸残基,没有已知的胞吞作用基序。在本研究中,我们已经确定甘露糖6-磷酸/胰岛素样生长因子II受体(M6P/IGFIIR)是CD26的结合蛋白,CD26碳水化合物部分的甘露糖6-磷酸(M6P)残基对于CD26与M6P/IGFIIR的结合至关重要。在人外周血淋巴细胞中,T细胞活化导致甘露糖6磷酸化CD26。此外,CD26与抗CD26抗体的交联不仅诱导了CD26的封顶和内化,还诱导了CD26与M6P/IGFIIR的共定位。最后,添加M6P可抑制CD26交联内化和CD26介导的T细胞共刺激诱导的T细胞增殖,但不受葡萄糖- 6-磷酸或甘露糖- 1-磷酸抑制。这些结果表明甘露糖6磷酸化CD26与M6P/IGFIIR之间的相互作用可能在CD26介导的T细胞共刺激信号传导中发挥重要作用。
英文摘要
CD26 is the T cell activation antigen and also known to bind the adenosine deaminase (ADA) and have a dipeptidyl peptidase IV (DPPIV) activity. Cross-linking of CD26 and CD3 with immobilized monoclonal antibodies can deliver a second costimulatory signal and contribute to T cell activation. Our earlier studies revealed that the cross-linking of CD26 induced internalization of the molecules, subsequent tyrosine phosphorylation of signaling molecules and resulted in an enhanced proliferating responses of T cells. Although these findings suggests the importance of internalization in the function of CD26. CD26 has only 6 amino acid residues in its cytoplasmic region with no known motif for endocytosis. In this study, we have identified the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) as the binding protein for CD26, and the mannose 6-phosphate (M6P) residues in carbohydrate moiety of CD26 is critical for the binding between CD26 and M6P/IGFIIR. In human peripheral blood lymphocytes, T cell activation resulted in the mannose 6-phosphorylation of CD26. In addition, the cross-linking of CD26 with an anti-CD26 antibody induced not only capping and internalization of CD26 but also colocalization of CD26 with M6P/IGFIIR. Finally, internalization of CD26 by cross-linking and T cell proliferation induced by CD26 mediated T cell costimulation were inhibited by the addition of M6P, but not by the glucose 6-phosophate or mannose 1-phosphate. These results indicate that the interaction between mannose 6-phosphorylated CD26 and M6P/IGFIIR may play an important role in CD26-mediated T cell constimulatory signaling.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Ohashi Y, Iwata S, Kamiguchi K, Morimoto C.: "Tyrosine Phosphorylation of Cas-L is a Critical Element for T Cell Receptor- and β1 Integrin-induced T Lymphocyte Migration"J. Immunol.. 163. 3727-3734 (1999)
Ohashi Y、Iwata S、Kamiguchi K、Morimoto C.:“Cas-L 的酪氨酸磷酸化是 T 细胞受体和 β1 整合素诱导的 T 淋巴细胞迁移的关键元素”J.Immunol.. 163. 3727-3734 (1999 )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hegen M: "Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase." Immunol.90. 257-264 (1997)
Hegen M:“抗体交联 CD26 会诱导酪氨酸磷酸化和丝裂原激活蛋白激酶的激活。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hosono O, Homma T, Kobayashi H, Munakata Y, Nojima Y, Iwamoto A, and Morimoto C.: "Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals"Clin. Immunol.. 91. 295 (2
Hosono O、Homma T、Kobayashi H、Munakata Y、Nojima Y、Iwamoto A 和 Morimoto C.:“HIV-1 感染者血浆可溶性 CD26 的二肽基肽酶 IV 酶活性降低及其与 HIV-1 RNA 的负相关”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kamiguchi K, Tachibana K, Ohashi Y, Fujita H, Iwata S, and Morimoto C.: "Cas-L is required for β1 integrin-mediated costimulation in T cells"J. Immunol.. 163. 563-568 (1999)
Kamiguchi K、Tachibana K、Ohashi Y、Fujita H、Iwata S 和 Morimoto C.:“T 细胞中 β1 整合素介导的共刺激需要 Cas-L”J. 163. 563-568 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
    • 批准号:
      24659401
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
    • 批准号:
      22650223
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
    Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
    • 批准号:
      17109011
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $71.72万
    • 财政年份:
      2005
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    海外基金